Archives

David K. Boyer Jr., a director at Truist Financial Corp., executed a sale of 3,986 common shares on July 23, 2026, at a price of $50.70 per share, according to a regulatory filing disclosed on July 27, 2026. Following the transaction, Boyer's direct beneficial ownership in the Charlotte-based financial services company totaled 10,270.342 shares. The filing provides insight into insider trading activity at the major regional bank as the company continues operations in the current market environment.

• July 27, 2026 10:14 AM PDT
• Anjali Anand

Artificial intelligence adoption continues expanding across government and enterprise markets as secure data platforms become increasingly important for modernization, operational efficiency, and long-term digital transformation. Tickers Used Palantir Technologies (NASDAQ:PLTR) – TechnologyNvidia (NASDAQ:NVDA) – Technology

• July 27, 2026 09:56 AM PDT
• Anmol Khazanchi

Bank of Montreal has issued $1.1 million in Trigger Callable Contingent Yield Notes due July 28, 2031, linked to the Russell 2000 Index, S&P 500 Index, and EURO STOXX 50 Index. The notes, which carry substantial downside risk, were priced on July 20, 2026, with a settlement date of July 27, 2026. The structured debt offering features quarterly contingent coupon payments contingent upon performance barriers and full downside exposure to the least performing of the three equity indexes.

• July 27, 2026 09:54 AM PDT
• Shwetambri Chauhan

Patrick E. Bowe, a director of Andersons Inc. (NASDAQ: ANDE), sold 3,534 shares of common stock on July 22, 2026, at a price of $80.53 per share, according to a regulatory disclosure filed with the Securities and Exchange Commission on July 27, 2026. Following the transaction, Bowe's direct beneficial ownership totaled 74,874.6324 shares. The transaction was executed under a Rule 10b5-1 trading plan, which allows company insiders to establish predetermined trading arrangements.

• July 27, 2026 09:23 AM PDT
• Aakashdeep

Frederic J. Winssinger, a director at USANA Health Sciences Inc., acquired 1,632 shares of common stock on July 23, 2026, through the vesting of restricted stock units, according to a regulatory disclosure filed July 27, 2026. The transaction brings Winssinger's direct beneficial ownership to 9,733 shares. The disclosure reflects a routine equity compensation event tied to the company's compensation structure for board members and executives.

• July 27, 2026 09:22 AM PDT
• Vinay Lochav

USANA Health Sciences Inc. disclosed that Timothy E. Wood, a director of the company, acquired 1,632 shares of common stock and 1,632 restricted stock units on July 23, 2026. The transaction, reported through an SEC Form 4 filing, demonstrates insider confidence in the nutritional products company. Wood's total beneficial ownership of common stock increased to 12,245 shares following the acquisition.

• July 27, 2026 09:22 AM PDT
• Nitish Kishor

Andersons Inc. (NASDAQ: ANDE) director Gary A. Douglas completed multiple security transactions on July 21 and 22, 2026, according to a disclosure filed with the Securities and Exchange Commission. The transactions included the acquisition of common stock through dividend reinvestment and the vesting of restricted share units granted in prior years as part of the company's annual equity compensation program. Douglas's beneficial ownership in the agricultural and grain merchandising company increased following these transactions.

• July 27, 2026 09:22 AM PDT
• Anjali Anand

USANA Health Sciences, a leader in nutritional products, has disclosed recent stock transactions involving its director, Peggie Pelosi. This update highlights the acquisition and disposition of shares, which may be of interest to investors monitoring insider activity and ownership changes within the company.

• July 27, 2026 09:12 AM PDT
• Manish Choudhary

USANA Health Sciences Inc. has disclosed a significant acquisition of restricted stock units by its director, Gilbert A. Fuller. This transaction, reported on July 27, 2026, highlights the ongoing commitment of company leadership to align their interests with those of shareholders. Investors may find this development noteworthy as it reflects confidence in the company's future performance.

• July 27, 2026 09:12 AM PDT
• Anjali Anand

USANA Health Sciences, a prominent player in the nutritional supplements market, has disclosed a notable stock transaction involving its director, Nixon J. Scott. The transaction, which took place on July 23, 2026, involves the acquisition of restricted stock units, raising interest among investors regarding potential implications for the company's governance and stock performance.

• July 27, 2026 09:12 AM PDT
• Anjali Anand